Delayed-onset neutropenia in a patient receiving rituximab as treatment for refractory kidney transplantation.
Mitsuhata
Naoki
N
Fujita
Ryuji
R
Ito
Seiichi
S
Mannami
Makoto
M
Keimei
Kojima
K
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab